Arch Venture Fund VII LP Insider Trading $JUNO Juno Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arch Venture Fund VII LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arch Venture Fund VII LP. Arch Venture Fund VII LP is 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in Receptos, Inc. ($RCPT) and 10% Owner in 908 Devices Inc. ($MASS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Juno Therapeutics, Inc. ($JUNO) and 10% Owner in Sage Therapeutics, Inc. ($SAGE).
Arch Venture Fund VII LP in Juno Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Arch Venture Fund VII LP: 10% Owner
Holdings: 10,552,390 shares
Current Value: $219,067,616
Latest Transaction: Mar 17 2016
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Arch Venture Fund VII LP in Juno Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, MASS, AGIO, JUNO, RCPT, SAGE, SYRS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2016 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 10,552,390 | 11.6 M to 10.6 M (-8.66 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 457,875 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 3,747,500 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Option Exercise | C | 0.00 | 6,250,000 | 0 | 0 | |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 457,875 | 0 | 11,552,390 | 11.1 M to 11.6 M (+4.13 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 3,747,500 | 0 | 11,094,515 | 7.3 M to 11.1 M (+51.01 %) |
| Dec 23 2014 | JUNO | Juno Therapeutics, ... | Arch Venture Fund VII LP | 10% Owner | Buy | C | 0.00 | 6,250,000 | 0 | 7,347,015 | 1.1 M to 7.3 M (+569.73 %) |
Page: 1